EORTC-1419-BTG

Back to Clinical Trials Database

Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma

Study documentation

Trial Status	Closed to Patient Entry
Dates	Date of activation: 29-Jun-2015
Data management at EORTC	Yes
Design	Cross-sectional Not randomized / N.A.
Targeted Sample size	EORTC Groups: 240 - All Groups: 640
Treatment	None
Study Staff	Michael Weller (Study Coordinator) , UniversitaetsSpital Zurich - Neurology Clinic, Zurich Lucia Gonzalez (Clinical Operations Manager) , EORTC Headquarters, Brussels Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels Hafida Lmalem (Imaging Officer) , EORTC Headquarters, Brussels Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Davide Passariello (Project Manager) , EORTC Headquarters, Brussels Miriam Presas (Junior RAM) , EORTC Headquarters, Brussels Caroline Quoilin (Medical representative) , EORTC Headquarters, Brussels Maarten Spruyt (Data Manager) , EORTC Headquarters, Brussels Tina Verschuere (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels Xiao Mang Zhou (Junior RAM) , EORTC Headquarters, Brussels
Type of cancer	Brain
Participating groups	EORTC Brain Tumor Group Brain Tumor Funders' Collaborative
Recruiting centers	APHP Hop Univ Paris Seine-Saint-Denis- Hop Avicenne (Bobigny, France) APHP Nord - Univ De Paris Cite - Hop. Saint Louis (Paris, France) APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (PARIS, France) Amsterdam UMC - locatie VUMC (Amsterdam, Netherlands) Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy) Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Giovanni - Dipartimento Neuroscienze (Torino, Italy) CHRU de Lille (LILLE CEDEX, France) CHU Amiens Picardie - Site Sud (Amiens, France) CHU Lyon - Hopital neurologique Pierre Wertheimer (BRON CEDEX, France) CHU de Nice - Hopital Pasteur (NICE, France) Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland) Dana-Farber Cancer Institute & Harvard Medical School (Boston, United States of America) Diagnostic & Therapeutic Center of Athens Hygeia Hospital S.A. (Athens, Greece) Erasmus MC (Rotterdam, Netherlands) Haaglanden MC - locatie Antoniushove ( Leidschendam, Netherlands) Haaglanden MC - locatie Antoniushove ( Leidschendam, Netherlands) Hopital Universitaires Erasme (Brussels, Belgium) Hopital de La Timone (APHM) (MARSEILLE CEDEX 5, France) IRCCS - Istituto Oncologico Veneto (Padova, Italy) Institut du Cancer de Montpellier (MONTPELLIER CEDEX 5, France) Klinikum Rechts der isar Der Technische Universitaet Muenchen - Klinikum Rechts Der Isar (Muenchen, Germany) Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany) Penn State College of Medicine, Hershey Medical Center-Penn State Neuroscience Institute (Hershey, United States of America) Prince Of Wales Hospital (Randwick - Sydney, Australia) UniversitaetsKlinikum Heidelberg - Head Hospital (Heidelberg, Germany) UniversitaetsSpital Zurich (Zurich, Switzerland) Universitaetsklinikum - Essen (Essen, Germany) Universitaetsklinikum Bonn (Bonn, Germany) Universitaetsklinikum Carl Gustav Carus (TUD) (Dresden, Germany) Universitaetsklinikum Freiburg - Klinik fuer Neurochirurgie (Freiburg, Germany) Universitaetsklinikum Regensburg (Regensburg, Germany) Universitaetsklinikum Wien - AKH unikliniken (Vienna, Austria) University Hospital Frankfurt -Senckenberg Institute of Neurooncology (Frankfurt am Main, Germany) University of California (San Francisco, United States of America)
Protocol summary	http://clinicaltrials.gov/study/NCT03770468
NCT number	NCT03770468
Financial Support	CH grant